DdI approval offers second chance.
Albert
S G
SG
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D016049:Didanosine